This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Matthew G Ewend
Introduction
Matthew G Ewend is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of stem cell delivery systems. His innovative work aims to improve therapeutic outcomes for patients undergoing treatment for cancer.
Latest Patents
Matthew G Ewend holds a patent for "Delivery vehicles for stem cells and uses thereof." This patent describes a biocompatible scaffold that comprises stem cells, designed for intracavity administration following the surgical removal of a tumor. The scaffold is pliable and allows stem cells to migrate towards cancerous or damaged tissue. Additionally, the stem cells can be loaded with therapeutic agents and/or reporter molecules. The patent outlines methods for forming the scaffold and its various applications.
Career Highlights
Matthew G Ewend is affiliated with the University of North Carolina at Chapel Hill, where he conducts research and develops innovative solutions in the field of regenerative medicine. His work focuses on enhancing the efficacy of stem cell therapies, which has the potential to transform treatment protocols for cancer patients.
Collaborations
Matthew has collaborated with notable colleagues, including Shawn D Hingtgen and Julio Rodriguez Bago. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their shared field of research.
Conclusion
Matthew G Ewend's contributions to stem cell delivery systems exemplify the innovative spirit of modern biomedical research. His work not only advances scientific knowledge but also holds promise for improving patient care in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
